Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial

BACKGROUND: The efficacy of entecavir (ETV) add-on peg-interferon therapy compared with ETV monotherapy in treatment-naïve hepatitis B virus (HBV) patients remains controversial. We investigated whether adding peg-interferon to ongoing ETV treatment leads to a better curative effect or not. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing-Mao, Chen, Li-Ping, Wang, Ya-Jie, Lyu, Bei, Zhao, Hong, Shang, Zhi-Yin, Li, Jun, Fan, Zhen-Yu, Wu, Sheng-Di, Ming, Xiao, Li, Xian, Huang, Shao-Ping, Cheng, Ji-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401765/
https://www.ncbi.nlm.nih.gov/pubmed/32568867
http://dx.doi.org/10.1097/CM9.0000000000000857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401765/
https://www.ncbi.nlm.nih.gov/pubmed/32568867
http://dx.doi.org/10.1097/CM9.0000000000000857

Ejemplares similares